Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
Depo Progestin
Product Overview
Development Status:
Limited Market Approval
Target:
Female
Mode:
Hormonal
Delivery Type:
Injectable
Duration Type:
Long-acting
Description:
Three month contraceptive injection containing 150mg Depot Medroxyprogesterone Acetate (DMPA). It is manufactured by Harsen in Indonesia and procured and supplied by DKT International.
Updated date:
March 20, 2015
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
medroxyprogesterone acetate
Potential Multi-Purpose Technology (MPT):
No
Regimen:
one injection every 3 months
Duration:
3 months
Dose:
150 mg
Partner:
DKT International
,
Harsen
Status
Project Phase:
Post-development
Project Stage:
Marketed
Programmatic Considerations
Considerations:
A potential alternative to Pfizer's DMPA product.
Additional Information
Download Product Report
